The Patent Lawyer - Logo
Rotating Image Link

The Patent Lawyer

News

The latest IP news –  to join our panel of Patent news correspondents, please contact us

 

Sign up to our newsletter
Best practices for drafting strong patent claims

Best practices for drafting strong patent claims

In the life span of any business, the investment goes way beyond the financial aspects. It's the years of dedication, contemplating, experimenting, and actively refining your idea of a product or service cut through the market. From the moment an idea is born,...

UK Government decides not to reduce or limit R&D tax credits

UK Government decides not to reduce or limit R&D tax credits

The UK Government’s 2024 Budget, while squarely focused on tax increases and revenue measures, suggests a pragmatic recognition by the new Labour administration that sustainable tax receipts are ideally underpinned by economic growth and wealth creation. In a global...

Calcutta High Court issues IP Division Rules

Calcutta High Court issues IP Division Rules

The Calcutta High Court recently adopted the much-awaited Intellectual Property Rights Division Rules, 2023 (Calcutta IPD Rules), making it the third High Court in India, after Delhi and Madras, to implement specialized regulations for IP matters. While the Calcutta...

How I would use AI to steal your design… and what you can do about it

How I would use AI to steal your design… and what you can do about it

To protect our designs, ideas, and innovations, we must think like an infringer. May AI allow bad actors to knock off your design… and get away with it? First, we need to understand AI-assisted design. Like all new tech, AI will follow Amara’s law. We overestimate the...

AstraZeneca challenges Axelpharm’s cancer drug patent

AstraZeneca challenges Axelpharm’s cancer drug patent

AstraZeneca is a world-renowned pharmaceutical company. It owns many patents in Russia and takes steps to protect them against encroachers. Its medicines are exempt from sanctions because they are mainly used for the life-preserving treatment of cancer. Axelpharm, a...

Proposal for a regulation on standard essential patents

On 27 April 2023 the European Commission presented its proposal for a new regulatory framework for the licensing of standard essential patents (SEPs) in the EU. The draft regulation seeks to '(i) make available detailed information on SEPs and existing FRAND terms and...

Gilead wins: high-stakes battle over HIV drug patents

In the hallowed halls of intellectual property (IP) and the pharmaceutical industry, Gilead Sciences' recent victory over the US government is a game changer, folks. This isn't just about Gilead shaking off the government's patent claims like a dog shaking off water;...

Unified Patent Court: continued preparations for its imminent launch

Unified Patent Court: continued preparations for its imminent launch

The implementation roadmap for the Unified Patent Court (UPC) was released in October 2022 by the UPC Preparatory team. The roadmap displays the key activities and milestones for the UPC in the lead up to its scheduled launch on June 1, 2023. One of those major...

Evergreening of patents: an elixir of life for pharmaceutical companies

Evergreening of patents: an elixir of life for pharmaceutical companies

“Mindless habitual behaviour is the enemy of innovation.”- Rosabeth Moss Kanter Grant of a patent is a monopoly right given exclusively to an inventor for a limited period of time. Such an invention should be new, non- obvious, and a useful product or process. In the...

Mental Health Awareness Week: get help!

Mental Health Awareness Week: get help!

Angus Lyon, LawCare volunteer and former solicitor who now works counselling lawyers online, writes about anxiety in the legal profession for Mental Health Awareness Week. There’s an old New Yorker cartoon by Danny Shanahan. Panel 1 shows Timmy floundering in a fast...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

The Patent Lawyer - Logo

Subscribe To Our Newsletter

Would you like to receive our popular weekly news alerts straight to your inbox? Solely patent focused and only sent once a week means you can guarantee there will be something you are interested in reading instead of clogging up your inbox with junk. Sign up now!

You have Successfully Subscribed!